Ratings by Nephron (Tom DeBourcy)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/9/2025 | CareDx, Inc | CDNA | Upgrade | Buy (Hold) |
19.25 (28.76) |
49.4% | Details | |
| 7/9/2025 | Quanterix Corp. | QTRX | Downgrade | Hold (Buy) |
6.54 (3.88) |
-40.67% | Details | |
| 12/11/2024 | IDEXX Laboratories | IDXX | Upgrade | Buy (Hold) |
444.72 (564.21) |
26.87% | Details | |
| 12/11/2024 | Neogen | NEOG | Downgrade | Hold (Buy) |
13.17 (9.65) |
-26.73% | Details |
